Remove 2002 Remove Digital Health Remove Drug Development
article thumbnail

Teladoc Livongo merger: what went wrong with the 'one-stop shop for virtual care' strategy?

Lloyd Price

The market for digital health is maturing. When the Teladoc Livongo merger was announced in 2020, the market for digital health was still in its early stages. However, the market has matured since then, and there are now a number of other digital health companies competing with Teladoc.

article thumbnail

Virtual Care – negotiating barriers to adoption offers glimpses of an exciting future

Lloyd Price

It may be a good while before we reach pre-cognitive techniques to ward off disease and accidents, but virtual reality is forging radical recalibrations of everything from drug discovery to bedside care in both the home and the hospital setting. Some of the recent deals underscore the importance of virtual care in the pharmaceutical industry.’